GHELARDINI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 46.350
EU - Europa 45.851
AS - Asia 19.583
SA - Sud America 3.024
AF - Africa 588
OC - Oceania 351
Continente sconosciuto - Info sul continente non disponibili 11
Totale 115.758
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 45.814
PL - Polonia 24.749
RU - Federazione Russa 8.824
SG - Singapore 5.339
CN - Cina 4.386
HK - Hong Kong 3.181
IT - Italia 2.973
BR - Brasile 2.498
VN - Vietnam 2.393
IE - Irlanda 2.255
SE - Svezia 1.770
KR - Corea 1.577
DE - Germania 1.091
FI - Finlandia 1.065
FR - Francia 918
UA - Ucraina 756
GB - Regno Unito 735
IN - India 659
ID - Indonesia 400
AU - Australia 342
CA - Canada 298
JP - Giappone 275
BD - Bangladesh 243
JO - Giordania 240
TR - Turchia 230
AR - Argentina 208
NL - Olanda 180
CI - Costa d'Avorio 142
IQ - Iraq 137
MX - Messico 137
ES - Italia 119
ZA - Sudafrica 102
CH - Svizzera 97
PK - Pakistan 83
EC - Ecuador 81
BE - Belgio 78
NG - Nigeria 59
MA - Marocco 58
CO - Colombia 50
SC - Seychelles 49
SA - Arabia Saudita 47
EG - Egitto 45
VE - Venezuela 45
PY - Paraguay 43
PT - Portogallo 42
UZ - Uzbekistan 39
PE - Perù 37
AE - Emirati Arabi Uniti 34
CL - Cile 34
PH - Filippine 32
TN - Tunisia 29
AT - Austria 28
AZ - Azerbaigian 28
IL - Israele 28
RO - Romania 27
TH - Thailandia 27
LT - Lituania 26
IR - Iran 25
JM - Giamaica 25
KE - Kenya 25
NP - Nepal 25
TW - Taiwan 21
LB - Libano 20
DZ - Algeria 18
AL - Albania 17
CZ - Repubblica Ceca 16
KZ - Kazakistan 15
MY - Malesia 15
BG - Bulgaria 14
UY - Uruguay 14
ET - Etiopia 13
SN - Senegal 13
BJ - Benin 12
BO - Bolivia 12
OM - Oman 12
CR - Costa Rica 11
DO - Repubblica Dominicana 11
HN - Honduras 11
BH - Bahrain 10
KG - Kirghizistan 10
GR - Grecia 9
NZ - Nuova Zelanda 9
AM - Armenia 8
HR - Croazia 8
LV - Lettonia 8
PS - Palestinian Territory 8
DK - Danimarca 7
GT - Guatemala 7
AO - Angola 6
EU - Europa 6
KW - Kuwait 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
BB - Barbados 5
GE - Georgia 5
LA - Repubblica Popolare Democratica del Laos 5
PA - Panama 5
QA - Qatar 5
SV - El Salvador 5
Totale 115.677
Salva come PNG Salva come JPEG
Città #
Warsaw 24.727
Santa Clara 8.451
Ashburn 5.593
Fairfield 4.142
Singapore 3.798
Hong Kong 2.686
Dublin 2.243
Woodbridge 1.953
Chandler 1.952
Seattle 1.738
Cambridge 1.654
Houston 1.502
Seoul 1.443
Wilmington 1.429
San Jose 1.423
Jacksonville 1.088
Beijing 1.032
Council Bluffs 847
Altamura 738
Ann Arbor 737
Hefei 705
Lawrence 690
The Dalles 660
Princeton 624
Ho Chi Minh City 622
Los Angeles 584
Florence 561
Buffalo 549
Lauterbourg 504
Helsinki 488
Dong Ket 445
Hanoi 439
Mumbai 393
Dallas 377
Boston 373
Moscow 362
Boardman 353
Jakarta 311
Medford 310
New York 310
Melbourne 294
San Diego 289
Munich 258
Paris 245
Tokyo 241
Shanghai 228
Phoenix 221
São Paulo 202
Milan 187
Kent 154
Clifton 148
Abidjan 142
Falls Church 141
London 126
Izmir 121
Rome 113
Frankfurt am Main 112
Orem 108
Turku 108
Norwalk 99
Redondo Beach 99
Chicago 95
Guangzhou 88
Da Nang 84
Tianjin 84
Hillsboro 79
Bern 74
Toronto 74
Seongnam 73
Brussels 70
Montreal 69
Rio de Janeiro 69
Brooklyn 67
Haiphong 67
Amsterdam 62
Washington 61
Chennai 58
Baghdad 56
Lappeenranta 53
San Francisco 51
Abuja 50
Andover 47
Barcelona 47
Belo Horizonte 46
West Jordan 46
Denver 43
Curitiba 42
Johannesburg 42
Brasília 40
Frankfurt Am Main 40
Amman 39
Atlanta 39
Auburn Hills 39
Verona 39
Dearborn 38
Yubileyny 38
Biên Hòa 36
Manchester 36
Philadelphia 36
Siena 36
Totale 84.625
Salva come PNG Salva come JPEG
Nome #
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 634
M1 receptor activation is a requirement for arecoline analgesia. 610
LOCAL ANAESTHETIC AVTIVITY OF ESSENTIAL OIL OF LAVANDULA ANGUSTIFOLIA 524
Antinociceptive property of the nicotinic agonist AG4 in rodents 518
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 429
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 411
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 409
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 403
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 401
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 389
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 388
Ryanodine receptors are involved in muscarinic antinociception in mice. 388
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 385
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 377
Acute effect of Capparis spinosa root extracts on rat articular pain 375
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 367
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 366
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 364
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 363
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 360
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 358
Neurotransmitter role of endogenous morphine in CNS. 357
Synthesis of novel cognition enhancer with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at gamma-aminobutyric acid type A (GABAA) receptor. 357
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 356
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 355
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 355
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 355
Design, synthesis and binding affinity of new nicotinic ligands 350
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 348
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 343
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 342
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 337
Local anaesthetic activity of beta-caryophyllene. 335
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 334
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 333
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 333
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 332
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 332
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 331
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 330
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 330
Delay of morphine tolerance by palmitoylethanolamide 329
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 328
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 326
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 326
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 323
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 322
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 322
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 320
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 319
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 318
Antisense knockdown of the Shaker Kv1.1 gene family abolishes the central stimulatory effect of amphetamines in mice and rats. 318
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 318
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 317
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 316
Methylamine: a new endogenous modulator of neuron firing? 316
The pharmacological basis of opioids 316
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 314
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 314
Role of intracellular calcium in acute thermal pain perception 314
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 313
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 313
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 313
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 312
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 311
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 311
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 311
THE REDUCTION OF FOOD INTAKE INDUCED IN MICE BY BENZYLAMINE AND ITS DERIVATIVES 310
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 309
Effect of K+ channel modulation on mouse feeding behaviour 308
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 308
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 307
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 307
Baclofen antinociception is prevented by ICV injection of pertussis toxin and by an aODN to the mKv1.1 potassium channel.. 306
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 304
Prochlorperazine induces central antinociception mediated by the muscarinic system. 304
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 304
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 304
CENTRAL CHOLINERGIC CHALLENGING OF MIGRAINE BY TESTING SECOND-GENERATION ANTICHOLINESTERASE DRUG 303
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin 303
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 302
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 301
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 301
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 300
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 299
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 299
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 298
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 297
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 296
THE CENTRAL CHOLINERGIC SYSTEM HAS A ROLE IN THE ANTINOCICEPTION INDUCED IN RODENTS AND GUINEA-PIGS BY THE ANTIMIGRAINE DRUG SUMATRIPTAN 296
Signaling pathway of morphine induced acute thermal hyperalgesia in mice. 295
Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations 295
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. 295
A Series of COX-2 Inhibitors Endowed with NO-Releasing Properties: Synthesis, Biological Evaluation, and Docking Analysis 295
Memory facilitation with atropine: a paradoxical effect 294
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 294
Effects of Hypericum perforatum extract on oxaliplatin-induced neurotoxicity: in vitro evaluations 294
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 293
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 293
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 293
Totale 33.831
Salva come PNG Salva come JPEG
Categoria #
all - tutte 286.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021812 0 0 0 0 0 0 0 0 0 0 0 812
2021/20224.209 115 372 409 159 141 239 172 309 262 302 662 1.067
2022/20239.590 964 1.980 444 564 682 1.670 1.325 525 928 59 289 160
2023/20243.915 172 407 670 187 268 562 162 893 83 198 187 126
2024/202525.998 876 2.737 1.729 3.615 7.326 3.327 612 1.429 1.548 783 1.088 928
2025/202628.468 3.041 3.923 2.478 2.634 3.254 1.404 3.594 1.708 2.332 2.221 1.583 296
Totale 116.637